Medication info
Yutopen Tablet

Yutopen Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
Pale yellow, rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200805752 · Notified 2008.05.23 · Insurance code 640004600

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to administer an additional dose of this medicine after dialysis to maintain analgesic effect. Patients with hepatic impairment For patients with moderate hepatic impairment, carefully consider extending the dosing interval. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and the dose should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, regular monitoring should be performed to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute or chronic pain from moderate to severe levels.

How to take

Adult dose

Elderly patients Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to administer an additional dose of this medicine after dialysis to maintain analgesic effect. Patients with hepatic impairment For patients with moderate hepatic impairment, carefully consider extending the dosing interval. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and the dose should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, regular monitoring should be performed to determine whether treatment with this medicine should be continued.

Precautions

This medication may cause liver damage in individuals who drink alcohol regularly, specifically more than three drinks a day, thus it is essential to consult a doctor or pharmacist. If severe reactions such as rashes or blisters appear during treatment with this medication, it should be discontinued immediately and medical personnel should be informed. The ingredients in this medication may cause seizures, so patients with a history of seizures or those at risk should use it with caution. Rarely, serious allergic reactions may occur while taking this medication. Symptoms such as difficulty breathing or hives necessitate an immediate visit to the hospital. Patients with severe respiratory diseases such as asthma may experience difficulty breathing when using this medication and should do so under the supervision of healthcare professionals. Taking this medication with alcohol or central nervous system depressants such as sedatives may result in severe drowsiness or respiratory depression; therefore, it is advisable not to combine them. Patients with head injuries or brain diseases should be cautious as this medication may increase intracranial pressure. This medication can cause psychological and physical dependence, thus it should be used under a doctor's guidance for prolonged periods. Patients with impaired liver function must consult a doctor before taking this medication, and caution should be exercised to ensure that the total daily dosage does not exceed 4,000 mg. In particular, patients with a fast metabolic rate of genes should strictly follow the doctor's instructions as the active ingredient of this medication may act more quickly in the body, increasing the risk of respiratory depression. This medication should not be used in children under 12 years old or in adolescents under 18 years of age post certain surgeries, and special caution is required for patients in these age groups. Patients with sleep apnea or at risk for hypoxia must periodically check for worsening symptoms after taking this medication, considering dose adjustments or discontinuation if necessary. This medication may cause hyponatremia, thus elderly patients or those with risk factors should have their serum sodium levels checked regularly. This medication may interact with certain drugs; therefore, if other medications are being taken, it is essential to inform the doctor or pharmacist. Women who are pregnant or may become pregnant should consult a doctor before taking this medication, while nursing mothers should avoid it for safety reasons. Drowsiness or dizziness may occur with this medication; therefore, it is advisable to avoid driving or performing hazardous tasks.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, drowsiness, sensory loss, tremors, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, elevated liver enzymes, generalized pruritus, cold sweats, urinary disorders, erectile dysfunction, weakness, chest pain, emotional abnormalities, chills, chest discomfort, fatigue, withdrawal syndrome, thirst, irritability, warmth sensation, weight loss, increased serum creatinine, anaphylactic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, emotional instability, delirium, suicidal thoughts, muscle hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, hypoprothrombinemia, fatal glutamic acid acidosis, hyponatremia, fixed rash, weakness, fever, edema, rigidity, syncope, congestive heart failure, dizziness, confusion, exacerbation of migraine, involuntary muscle contractions, dyspnea, asthma, exercise-induced dyspnea, cough, bronchitis, urinary retention, polyuria, renal function abnormalities, oliguria, rash, increased sweating, urticaria, dysphagia, tongue swelling, hypersalivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, loss of appetite, anxiety, depression, irritability, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, thrombocytopenia, palpitations, arrhythmias, tachycardia, exacerbation of hypertension, aortic stenosis, gastrointestinal bleeding, elevated cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal visual field, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, nausea, dizziness, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, dyspepsia, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory tract syndrome, facial flushing, agitation, irritability, hyperactivity, gastrointestinal symptoms, urticaria, rash, bronchospasm, toxic skin necrosis, allergic reactions, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system reactions, withdrawal symptoms, QT prolongation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air from entering, and the storage temperature should be maintained between 1 to 30 degrees Celsius. This will help preserve the effectiveness of the medication.

Appearance and packaging

Appearance

Pale yellow, rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.